Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Homocystinuria without methylmalonic aciduria is an inborn error of vitamin B12 (cobalamin) metabolism characterized by megaloblastic anemia, encephalopathy and, sometimes, developmental delay, and associated with homocystinuria and hyperhomocysteinemia. There are three types of homocystinuria without methylmalonic aciduria; cblE, cblG and cblD-variant 1 (cblDv1).
Biomarker and diagnostic research for homocystinuria without methylmalonic aciduria has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
1 clinical trial registered. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
43 publications have been identified in PubMed for homocystinuria without methylmalonic aciduria. Research spans Case Report / Case Series (33%), Review / Meta-Analysis (23%), and Basic Science / Preclinical (23%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 14 | 33% |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 3:51 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries |
10 |
23% |
Laboratory research | 10 | 23% |
Disease patterns and progression | 7 | 16% |
Testing and diagnosis research | 1 | 2% |
Clinical study results | 1 | 2% |
Ferreira DSM (2026). [PMID: 42115646](https://pubmed.ncbi.nlm.nih.gov/42115646/). *Nat Commun*. [Basic Science / Preclinical]
Cui X (2026). [PMID: 42065149](https://pubmed.ncbi.nlm.nih.gov/42065149/). *Medicine (Baltimore)*. [Review / Meta-Analysis]
Saini AG (2026). [PMID: 42158251](https://pubmed.ncbi.nlm.nih.gov/42158251/). *Front Nutr*. [Review / Meta-Analysis]
Olivieri G (2026). [PMID: 42231716](https://pubmed.ncbi.nlm.nih.gov/42231716/). *J Inherit Metab Dis*. [Review / Meta-Analysis]
Wang Q (2026). [PMID: 41890422](https://pubmed.ncbi.nlm.nih.gov/41890422/). *Frontiers in psychiatry*. [Case Report / Case Series]
Li MJ (2026). [PMID: 41371076](https://pubmed.ncbi.nlm.nih.gov/41371076/). *Molecular genetics and metabolism*. [Epidemiology / Natural History]
Tommolini ML (2025). [PMID: 40422885](https://pubmed.ncbi.nlm.nih.gov/40422885/). *Metabolites*. [Case Report / Case Series]
Heinken A (2025). [PMID: 40790789](https://pubmed.ncbi.nlm.nih.gov/40790789/). *Journal of inherited metabolic disease*. [Epidemiology / Natural History]
Aslan D (2025). [PMID: 41378236](https://pubmed.ncbi.nlm.nih.gov/41378236/). *Molecular syndromology*. [Case Report / Case Series]
Ren Y (2025). [PMID: 40231198](https://pubmed.ncbi.nlm.nih.gov/40231198/). *Metabolism open*. [Review / Meta-Analysis]